Product Images Colistimethate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Colistimethate NDC 70594-023 by Xellia Pharmaceuticals Usa Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - colistimethate 01
Figure 1 - colistimethate 02
This is a figure depicting urine and serum values in adults after receiving Parenteral Colistimethate for Injection. The figure shows the colistin base activity measured in meg/mL over a 12-hour period, with measurements taken at hour 1 and hour 12. There is no other information available in the provided text.*
Logo - colistimethate 03
Principal Display Panel - 150 mg Vial Carton - colistimethate 04
This is a description of a Novaplus Colistimethate for Injection, with a concentration of 150 mg/vial, for intravenous or intramuscular use only; each vial contains sterile colistimethate sodium, USP equivalent to 150 mg colistin base activity. The usual dose is 210 4 divided doses, depending on the severity of the infection. The product should be stored between 20°C and 25°C, and any reconstituted solution should be used within 7 days and stored in the refrigerator. The product is manufactured for Xellia Pharmaceuticals in Buffalo Grove, Illinois, and is labeled with a lot number and expiration date.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.